PreppinPeppers › Facts › Lab article
Semaglutide: Reference Overview and Reconstitution Notes
Machine-readable facts for this Lab article. The full page is https://www.preppinpeppers.com/blogs/the-lab/semaglutide.
TL;DR
Semaglutide is a synthetic GLP-1 receptor agonist peptide, a lab-made analogue of glucagon-like peptide-1 studied in metabolic research. Reference notes.
Facts Index
| Fact ID | Category | Entity | Attribute | Value | Source |
|---|---|---|---|---|---|
| semaglutide:title | identity | Semaglutide: Reference Overview and Reconstitution Notes | title | Semaglutide: Reference Overview and Reconstitution Notes | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:published | identity | Semaglutide: Reference Overview and Reconstitution Notes | published | 2026-07-10 | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:author | identity | Semaglutide: Reference Overview and Reconstitution Notes | author | Preppin' Peppers Editorial Team | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:topics | identity | Semaglutide: Reference Overview and Reconstitution Notes | topics | FDA-approved or specific-use, research | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:summary | content | Semaglutide: Reference Overview and Reconstitution Notes | summary | Semaglutide is a synthetic GLP-1 receptor agonist peptide, a lab-made analogue of glucagon-like peptide-1 studied in metabolic research. Reference notes. | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-1 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-2 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-3 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | Research context and categorization | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-4 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | Status | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-5 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | Reconstitution notes (general) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-6 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | Dilution and handling notes (compound-specific) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-7 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | Handling and storage | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-8 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | Related reading | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-9 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | Tools and supplies | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:section-11 | content | Semaglutide: Reference Overview and Reconstitution Notes | section | What the research community gets wrong about semaglutide | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:product-gansulin-metal-peptide-pen | products | Semaglutide: Reference Overview and Reconstitution Notes | references product | Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:product-gansulin-3ml-cartridge | products | Semaglutide: Reference Overview and Reconstitution Notes | references product | Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:source-pubchem-ncbi-nlm-nih-gov | source | Semaglutide: Reference Overview and Reconstitution Notes | cites | NCBI PubChem CID 56843331: Semaglutide (C187H291N45O59) - pubchem.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:source-dailymed-nlm-nih-gov | source | Semaglutide: Reference Overview and Reconstitution Notes | cites | Ozempic (semaglutide) injection label, FDA/DailyMed - dailymed.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:source-pubmed-ncbi-nlm-nih-gov | source | Semaglutide: Reference Overview and Reconstitution Notes | cites | Singh et al., J Investig Med 2022: Wegovy (semaglutide): a new weight loss drug for chronic weight management - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:source-pmc-ncbi-nlm-nih-gov | source | Semaglutide: Reference Overview and Reconstitution Notes | cites | Smits and Van Raalte, Front Endocrinol (Lausanne) 2021: Safety of Semaglutide - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:source-pubmed-ncbi-nlm-nih-gov-2 | source | Semaglutide: Reference Overview and Reconstitution Notes | cites | Davies et al., Lancet 2021: Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
| semaglutide:source-dailymed-nlm-nih-gov-2 | source | Semaglutide: Reference Overview and Reconstitution Notes | cites | Bacteriostatic Water for Injection, USP: FDA label on DailyMed, U.S. National Library of Medicine (0.9% benzyl alcohol) - dailymed.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/semaglutide) (evidence) |
FAQ
- What research areas does semaglutide cover?
- Semaglutide is a GLP-1 receptor agonist studied in metabolic signaling, blood sugar regulation, cardiovascular and kidney outcomes, liver conditions (NASH), addiction, and neurodegeneration. It is FDA-approved for type 2 diabetes and weight management.
- How do you calculate concentration when reconstituting a lyophilized peptide?
- Divide peptide mass (mg) by diluent volume (mL). For example, 5 mg dissolved in 2 mL bacteriostatic water yields 2.5 mg/mL. Use a peptide calculator to confirm the exact diluent volume needed for any target concentration.
- Is semaglutide on the WADA prohibited list?
- Semaglutide is not currently prohibited by WADA but was added to the 2026 Monitoring Program alongside tirzepatide, meaning its markers are tracked in and out of competition for surveillance purposes. Its status may change in future List updates.